Subsequently, we re-investigated in detail the patterns of gene amplification (GA) of PDGFRA, KIT, and KDR in those GBM specimens carrying GA, and its association with RB1 deletion and other clinical variables. The gene discussed is KDR; the disease is glioblastoma.